For now Johnson and Johnson's Covid-19 vaccine has been identified by the US International Development Finance Corporation to be manufactured in India with an aim to reach the one billion doses by end of 2022. Quad Summit's Vaccine Initiative: India's Biological E to Shoulder Manufacturing
For now Johnson and Johnson's Covid-19 vaccine has been identified by the US International Development Finance Corporation to be manufactured in India with an aim to reach the one billion doses by end of 2022. Quad Summit's Vaccine Initiative: India's Biological E to Shoulder Manufacturing
No comments:
Post a Comment